General Information of the Compound
Compound ID |
CP0020849
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
Show/Hide
|
||||||||||||||||||
Synonyms |
2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one
3',4',5,7-Tetrahydroxyflavan-3-ol
3',4',5,7-tetrahydroxyflavon-3-ol
3,3',4',5,7-Pentahydroxyflavone dihydrate
3,5,7,3',4'-Pentahydroxyflavone
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on
3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one
C.I . natural yellow 10
C.I. 75670
C.I. Natural Yellow 10
C.I. Natural red 1
C.I. Natural yellow 10 & 13
CI Natural Yellow 10
CU-01000012502-3
Cyanidelonon 1522
Flavin meletin
Flavonoid derivative 4
KSC-10-126
KSC-23-76
KUC104418N
KUC107684N
Kvercetin
Kvercetin [Czech]
LIM-5662
LNS-5662
Meletin
MixCom3_000183
Natural Yellow 10
P0042
PMID26394986-Compound-48
Q 0125
QUE
Quercetin
Quercetin content
Quercetin dihydrate
Quercetine
Quercetol
Quercitin
Quertin
Quertine
Sophoretin
T-Gelb bzw. grun 1
TNP00070
TNP00089
Xanthaurine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H10O7
|
||||||||||||||||||
Molecular Weight |
302.238
|
||||||||||||||||||
Canonical SMILES |
Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H
Show/Hide
|
||||||||||||||||||
InChIKey |
REFJWTPEDVJJIY-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
73123-10-1
74893-81-5
117-39-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04712, 5'-nucleotidase
Protein ID: PT01279, Adenosine receptor A3
Protein ID: PT05334, ATP-binding cassette sub-family C member 4
Protein ID: PT01546, ATP-dependent translocase ABCB1
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Protein ID: PT03308, G-protein coupled receptor 35
Protein ID: PT02516, Multidrug resistance-associated protein 1
Protein ID: PT05074, NADPH oxidase 4
Protein ID: PT01718, Nitric oxide synthase, inducible
Protein ID: PT01743, Polyunsaturated fatty acid 5-lipoxygenase
Protein ID: PT00901, Prostaglandin G/H synthase 2
Clinical Information about the Compound